Superficial injury of ankle and foot, unspecified

ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S90.9 Cause of death: ICD-10 — S90.9 2 out of 7 registries used, show all original rules.	224
4. Check minimum number of events None	224
5. Include endpoints None	224
6. Filter based on genotype QC (FinnGen only)	203

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S90
Name in latin: Laesio superficialis tarsi/pedis non specificata

NAME	ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE
CONTROL_EXCLUDE	ST19_INJURI_ANKLE_FOOT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S909
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S909
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Superficial injury of ankle and foot, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	203	129	74
Unadjusted period prevalence (%)	0.04	0.05	0.03
Median age at first event (years)	41.22	39.76	43.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
209: Matched controls
2090

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S90.9

ICD-10 Finland

Superficial injury of ankle and foot, unspecified

+∞

300.3

209

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

11.4

46.6

W22

ICD-10 Finland

Striking against or struck by other object(s)

6.8

22.9

X59

ICD-10 Finland

Exposure to unspecified factor

4.6

22.7

215

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.2

22.5

313

S93.4

ICD-10 Finland

Sprain and strain of ankle

5.2

18.6

102

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

6.4

16.9

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

5.5

14.0

S92.3

ICD-10 Finland

Fracture of metatarsal bone

26.3

12.7

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

9.6

10.6

N02AX02

ATC

tramadol; systemic, rectal

2.4

8.9

518

X58

ICD-10 Finland

Exposure to other specified factors

2.8

8.0

191

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

7.7

175

W19

ICD-10 Finland

Unspecified fall

3.5

7.6

Y94.8

ICD-10 Finland

Other leisure activity accident

7.4

7.1

J01FF01

ATC

clindamycin; systemic

2.4

7.1

321

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

7.0

134

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.1

6.7

L17

ICPC

Foot/toe symptom/complaint

2.2

6.6

399

S92.2

ICD-10 Finland

Fracture of other tarsal bone(s)

72.0

6.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

6.5

591

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

13.0

6.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

6.1

108

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

512

2.07

5.92

5.7

6.4

—

(3042936) Bacteria identified in Isolate by Culture

214

2.14

4.20

1.8

1.9

—

(3023368) Bacteria identified in Blood by Culture

401

1.86

3.90

5.4

3.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2.61

3.86

1.4

1.7

9.38

8.06

u/l

0.16

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

268

1.97

3.79

3.7

3.1

67.08

444.44

ng/l

1.44

176

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

666

1.75

3.78

7.6

6.0

1.23

1.22

mmol/l

0.67

624

(3032080) INR in Blood by Coagulation assay

643

1.74

3.67

13.2

10.1

1.19

1.15

inr

0.30

546

(3007853) Bacteria identified in Skin by Aerobe culture

202

2.01

3.35

2.1

1.6

—

(4024509) Urine culture

2.64

3.31

1.9

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

306

1.83

3.23

1.6

1.3

7.90

10.09

u/ml

0.11

123

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

338

1.76

2.97

1.5

1.3

12.85

26.12

iu/ml

1.29

103

(3027945) Reticulocytes/Erythrocytes in Blood

159

2.04

2.94

4.0

3.1

1.93

1.75

0.56

147

(3024561) Albumin [Mass/volume] in Serum or Plasma

666

1.62

2.87

5.6

4.5

36.18

36.80

g/l

0.51

644

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

4.58

2.82

1.1

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

303

1.76

2.78

2.0

1.8

1.45

1.35

0.88

270

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

8.50

2.76

1.4

3.2

113.40

129.67

—

(3018418) pH of Serum or Plasma

454

1.63

2.58

3.1

3.6

7.40

0.02

327

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

573

1.58

2.50

3.3

3.1

1028.51

27.06

ng/l

0.51

345

(3045414) Leukocytes [Presence] in Urine

162

1.92

2.47

1.4

1.9

0.00

estimate

-0.00

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.13

2.35

2.6

4.4

81.60

74.67

ng/l

0.09

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.13

2.35

1.4

—

(3027944) Amphetamines [Presence] in Urine

165

1.88

2.34

2.4

2.2

—

(3002030) Lymphocytes/Leukocytes in Blood

112

904

1.51

2.29

7.7

6.5

28.86

29.25

0.15

106

874

(3023323) Follitropin [Units/volume] in Serum or Plasma

129

1.97

2.28

1.3

1.5

17.22

19.35

iu/l

0.14

110

(3022313) Gas panel - Capillary blood

2.29

2.27

2.7

4.2

—

(3026008) Bacteria identified in Urine by Culture

468

1.56

2.24

2.5

2.7

—

(3045424) Erythrocytes [Presence] in Urine

2.20

2.19

1.4

1.9

0.00

estimate

—

(3027008) Opiates [Presence] in Urine

161

1.85

2.19

2.5

2.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

152

1316

1.57

2.19

6.2

3.9

11.77

9.49

mm/h

0.80

146

1230

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2.10

2.18

2.4

3.8

1.28

1.71

mmol/l

0.27

(3000850) Epithelial cells [#/volume] in Urine

366

1.60

2.17

2.4

2.7

7.68

8.55

e6/l

0.11

333

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

392

1.59

2.17

1.9

2.0

0.78

1.02

mg/l

0.42

294

(3037522) Nuclear Ab [Titer] in Serum

258

1.68

2.13

1.6

1.4

700.00

499.62

titre

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

527

1.53

2.12

2.2

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

163

1.83

2.11

2.5

2.4

—

(3028300) Cannabinoids [Presence] in Urine

163

1.83

2.11

2.5

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

528

1.52

2.10

3.0

3.2

19.15

51.87

e6/l

1.76

401

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2.89

2.02

1.0

1.5

1191.89

199.71

e6/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.47

1.88

1.5

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.93

1.88

2.0

2.1

23.88

25.22

nmol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.93

1.88

1.0

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

442

1.50

1.83

1.9

1.6

17.89

20.17

nmol/l

0.67

392

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

159

1413

1.52

1.82

5.6

4.3

14.60

14.65

pmol/l

0.09

150

1307

(3019198) Lymphocytes [#/volume] in Blood

117

983

1.43

1.78

7.1

6.6

2.13

1.89

e9/l

2.59

111

891

(3016879) Cocaine [Presence] in Urine

149

1.77

1.76

2.6

2.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

111

1.89

1.76

2.1

1.5

0.30

0.22

mg/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

667

1.43

1.73

2.3

1.9

94.97

94.48

pmol/l

0.03

336

(3006504) Eosinophils/Leukocytes in Blood

106

878

1.42

1.73

7.8

6.5

2.85

2.78

0.14

100

835

(42870588) Differential panel, method unspecified - Blood

593

1.44

1.72

6.8

6.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

112

1.87

1.71

1.2

1.4

—

(3019069) Monocytes/Leukocytes in Blood

106

880

1.42

1.70

8.0

6.6

8.19

8.57

0.73

100

841

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

162

1455

1.50

1.67

3.6

—

(3018095) Leukocytes [#/volume] in Urine

634

1.42

1.65

3.5

3.9

32.88

54.10

e6/l

0.37

431

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.98

1.65

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

380

1.49

1.64

2.2

2.5

325.33

342.27

umol/l

0.46

343

(3022096) Basophils/Leukocytes in Blood

105

875

1.40

1.62

8.1

6.6

0.78

0.68

0.98

826

(3001604) Monocytes [#/volume] in Blood

113

955

1.40

1.60

7.1

6.6

0.59

0.55

e9/l

1.02

103

842

(3044290) Cell count panel - Cerebral spinal fluid

2.75

1.59

1.0

1.6

—

(3006315) Basophils [#/volume] in Blood

113

956

1.40

1.59

7.1

6.6

0.05

0.04

e9/l

1.74

104

839

(40768797) Stomach Pathology biopsy report

219

1.60

1.59

1.1

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

420

1.46

1.54

3.4

2.1

2.77

2.68

mg/l

0.11

375

(3013290) Carbon dioxide [Partial pressure] in Blood

2.65

1.53

2.0

4.6

4.86

5.10

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.65

1.53

2.0

4.6

9.11

9.39

kpa

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

247

1.55

1.51

2.5

3.0

1.10

3.20

e6/l

2.08

118

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

185

1724

1.64

1.47

4.7

2.79

2.80

mmol/l

0.05

175

1633

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.84

1.44

6.0

9.0

24.58

25.03

mmol/l

0.13

(3017732) Neutrophils [#/volume] in Blood

227

1.54

1.37

3.7

3.4

5.21

5.30

e9/l

0.03

204

(3011288) Drugs identified in Urine by Screen method Nominal

113

1.75

1.37

3.9

3.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.99

1.36

3.6

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

122

1063

1.35

1.34

8.7

9.9

4.18

3.97

e9/l

0.50

112

941

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.41

1.30

1.5

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.82

1.29

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.82

1.29

2.2

1.7

17.98

24.23

ng/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

274

1.47

1.28

2.4

2.8

0.31

0.86

e6/l

3.24

143

(3035350) Ketones [Presence] in Urine by Test strip

112

970

1.33

1.25

3.1

3.6

0.00

estimate

-0.00

212

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

269

1.46

1.20

2.4

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.98

1.19

2.5

3.3

165.55

166.98

0.03

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.86

1.18

1.1

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.86

1.18

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.09

1.16

1.1

—

(3000991) Gas panel - Venous blood

127

1.64

1.16

8.0

8.8

—

(3028707) Methadone [Presence] in Urine by Screen method

1.80

1.16

2.8

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

110

958

1.31

1.15

3.1

3.6

0.00

estimate

-0.00

213

(3010421) pH of Blood

2.04

1.13

2.0

4.2

7.42

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.04

1.13

1.3

1.4

—

(3021589) Normoblasts [#/volume] in Blood

832

1.31

1.13

10.2

10.8

0.01

0.00

e9/l

0.22

682

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.87

1.11

2.3

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

766

1.31

1.10

8.4

6.4

1.22

1.21

mmol/l

0.64

665

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.41

1.09

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.81

1.09

1.8

1.7

2.22

8.78

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

464

1.35

1.09

2.8

3.1

0.19

0.31

e6/l

0.53

344

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

567

1.32

1.08

3.4

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

176

1650

1.42

1.05

4.3

4.1

5.66

5.71

mmol/l

0.21

165

1531

(3013115) Eosinophils [#/volume] in Blood

113

996

1.29

1.05

7.3

6.9

0.21

0.18

e9/l

0.85

108

891

(3032773) Endomysium IgG Ab [Titer] in Serum

2.30

1.04

2.4

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

111

977

1.29

1.04

3.3

3.7

0.00

estimate

-0.00

199

(3019150) Specific gravity of Urine by Refractometry

440

1.34

1.03

3.6

3.3

1.02

kg/l

0.60

284

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

146

1333

1.32

1.03

3.7

3.1

38.01

40.36

u/l

0.27

141

1287

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

189

1798

1.53

1.02

19.2

12.5

22.10

21.09

mg/l

0.16

165

1430

(4034850) Laboratory test

1.91

1.02

15.8

8.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

243

1.43

1.01

1.7

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

209

1.45

0.99

2.1

1.6

1254.94

1192.55

nmol/l

0.14

162

(3044640) Blood type and Crossmatch panel - Blood

564

1.30

0.99

3.0

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.20

0.98

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

134

1.54

0.96

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

21.38

—

(3048689) Calprotectin [Mass/mass] in Stool

317

1.36

0.95

3.5

2.0

92.20

98.31

ug/g

0.07

238

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.26

0.94

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

2.26

0.94

1.3

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

178

1.46

0.91

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

231

1.40

0.90

2.3

1.9

—

(3008898) HLA-B27 [Presence]

1.61

0.87

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

139

0.56

0.86

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

377

1.32

0.86

3.6

3.0

890.30

1059.96

ng/l

0.27

302

(40768443) Skin Pathology biopsy report

1.79

0.85

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1.96

0.85

3.3

2.9

35.50

40.29

umol/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

175

1658

1.34

0.81

6.8

5.1

1.78

1.81

mu/l

0.10

166

1564

(40761511) CBC panel - Blood by Automated count

194

1870

1.52

0.80

14.6

11.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.69

0.79

1.0

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

208

0.65

0.79

1.9

1.6

—

(3025159) Blasts/Leukocytes in Blood

150

1.44

0.77

9.4

5.6

0.00

0.06

—

(44806420) Estimation of glomerular filtration rate

2.11

0.75

1.4

2.2

—

(3015736) pH of Urine

788

1.23

0.72

3.0

3.3

6.25

6.21

0.12

477

(42529406) Shigella sp [Presence] in Stool by Culture

1.60

0.72

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.60

0.72

1.1

—

(21494755) Public health laboratory ask at order entry panel

260

0.70

0.72

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

740

1.23

0.71

3.0

3.4

1.23

0.01

estimate

0.53

182

(3023511) Choriogonadotropin [Units/volume] in Urine

1.54

0.71

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.95

0.71

1.4

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.58

0.71

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

342

1.29

0.70

1.5

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

0.70

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

162

1.40

0.69

1.3

51.86

136.76

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

102

1.51

0.69

2.6

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

165

1562

1.27

0.68

5.1

38.20

37.97

mmol/mol

0.10

155

1483

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

178

1701

1.31

0.68

4.2

4.3

1.42

1.45

mmol/l

0.37

168

1613

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

155

1.39

0.66

4.0

2.4

2254.59

8042.67

u/l

1.12

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.61

0.66

1.4

2.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1.74

0.64

3.6

1.9

13.50

13.08

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

174

1.36

0.63

1.8

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.62

0.62

4.5

1.5

8.26

7.14

ug/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1.68

0.62

1.4

19254.40

6272.95

e6/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

414

1.24

0.61

2.4

2.2

—

(3000492) Spirometry study

211

1.32

0.61

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.60

0.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.56

0.60

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

178

1708

1.28

0.60

4.3

4.71

4.68

mmol/l

0.13

170

1625

(3000494) Fungus identified in Specimen by Culture

203

1.32

0.59

1.4

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

285

1.27

0.59

2.2

1.6

224138293.48

45349275.82

pmol/l

0.36

258

(3029937) Albumin [Presence] in Urine by Test strip

520

1.22

0.59

3.0

3.6

0.00

estimate

-0.00

197

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

3.13

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.69

0.57

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.49

0.55

1.9

2.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

172

1648

1.25

0.55

15.9

11.7

90.88

90.27

ml/min/173m2

0.13

159

1489

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

817

1.18

0.53

3.1

2.6

—

estimate

—

(3000330) Specific gravity of Urine by Test strip

1.44

0.52

1.7

3.2

1.02

ratio

0.64

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

1.37

0.51

2.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

119

1.37

0.50

1.4

3.2

80.20

72.85

ml/min/173m2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.47

0.49

1.3

1.7

—

(3012544) pH of Venous blood

164

1.31

0.49

4.2

4.6

7.37

7.39

—

101

(3004716) Salmonella sp identified in Stool by Organism specific culture

120

1.36

0.48

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

560

1.18

0.47

1.3

1.4

0.52

1.25

u/ml

1.77

164

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1.44

0.46

1.0

1.3

—

71.50

—

(3012516) Albumin [Mass/volume] in Urine

422

0.82

0.45

3.8

3.3

35.09

64.44

mg/l

0.79

284

(3019225) pH of Specimen

130

1.33

0.45

3.7

4.2

7.32

7.33

0.03

101

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

353

1.20

0.43

2.0

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.64

0.43

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.40

0.43

1.2

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.63

0.43

1.5

1.6

—

(1616796) Gas panel - Central venous blood

1.58

0.42

1.6

4.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

566

1.16

0.41

2.6

3.0

0.00

0.01

estimate

0.50

169

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

4.0

—

53.48

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

224

0.79

0.39

2.2

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1.32

0.37

1.7

2.0

200.00

235.48

pmol/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

135

1.28

0.36

1.4

1.3

113.39

366.56

u/ml

1.11

124

(3019060) Gas panel - Arterial blood

0.64

0.36

19.8

3.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.41

0.35

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

1.41

0.35

1.3

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.41

0.35

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.37

0.34

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

0.67

0.33

25.2

7.1

24.12

24.81

mmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

420

1.15

0.33

2.1

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

429

0.86

0.32

4.3

3.9

6.98

10.08

mg/mmol

0.35

277

(3035933) Granulocytes/Leukocytes in Blood

1.36

0.31

5.1

3.0

60.29

57.86

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.70

0.31

2.0

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

120

1.27

0.31

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

206

0.81

0.30

1.4

1.6

1389.67

958.61

mu/l

0.37

179

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.26

0.29

1.3

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.26

0.29

1.1

—

11.26

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

158

1.22

0.29

2.6

2.3

25.86

31.47

u/l

1.11

131

(40768804) Tissue Pathology biopsy report

678

1.12

0.29

2.0

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

487

0.88

0.29

1.6

1.8

—

(1002224) Polysomnography panel

117

0.76

0.28

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.26

0.28

2.5

3.1

88.38

96.91

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

113

1.26

0.27

1.1

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

720

1.11

0.27

1.7

1.9

1.57

1.40

mmol/l

0.56

622

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

203

0.82

0.27

1.4

1.9

3.57

3.49

mmol/l

0.09

147

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.67

0.26

1.2

1.5

94.06

60.66

ug/l

—

(3036489) Thrombin time

1.24

0.26

2.2

2.8

19.89

21.09

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

143

1.21

0.24

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.29

0.23

1.2

1.5

—

(3035715) Granulocytes [#/volume] in Blood

1.26

0.22

4.8

3.5

4.01

4.41

e9/l

—

(3003694) ABO and Rh group [Type] in Blood

621

0.91

0.22

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

23.92

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

236.45

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

68.09

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.21

0.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.21

0.0

1.0

—

1169.66

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

8.3

—

9.32

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.21

0.0

1.9

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.21

0.0

1.2

—

7.38

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.21

0.0

7.4

—

9.38

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.7

—

39.00

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.21

0.0

1.7

—

34.69

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(40768800) Prostate Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.20

0.0

4.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(40768793) Breast Pathology biopsy report

1.23

0.20

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

259

0.87

0.20

1.8

2.0

3.68

3.42

ratio

0.45

201

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.14

0.19

1.3

2.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

214

1.14

0.18

2.5

2.8

0.63

0.71

ug/l

0.17

107

(3034770) Mitochondria Ab [Titer] in Serum

1.13

0.17

1.6

1.2

—

(3020891) Body temperature

1.17

0.16

9.1

5.2

37.08

36.96

°c

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.10

0.16

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.13

0.15

3.1

2.3

38.22

39.08

u/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

118

0.84

0.14

1.4

1.8

—

(4035726) Immunohistochemistry procedure

128

0.85

0.14

1.5

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

127

0.86

0.13

2.5

1.6

1.46

1.28

g/l

0.42

118

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.19

0.12

5.4

3.3

0.68

0.63

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.17

0.12

1.2

1.1

1.52

1.51

g/l

0.08

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

105

1.15

0.11

1.3

1.4

485.68

312.37

miu/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

382

0.93

0.11

1.9

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

594

0.94

0.10

2.4

2.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.15

0.10

1.2

1.1

0.95

0.88

g/l

0.33

(3025941) Bacteria identified in Stool by Culture

125

0.87

0.10

1.1

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

156

0.89

0.10

3.1

2.4

11.43

10.64

g/l

0.34

144

(40761536) Microorganisms panel - Urine sediment

166

0.90

0.10

3.1

3.5

—

(1761868) Lipid panel - Serum or Plasma

796

1.05

0.10

2.3

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.11

0.10

1.8

4.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

116

1.13

0.09

1.2

1.3

—

22.59

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.07

0.09

1.8

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.07

0.09

1.0

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

509

0.95

0.08

5.9

4.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.05

0.07

1.5

1.7

—

(3019977) pH of Arterial blood

157

1.09

0.07

15.3

7.3

7.39

7.42

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

122

0.90

0.07

3.7

4.0

1.23

mmol/l

0.06

107

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

111

0.90

0.06

1.3

1.5

1.18

0.97

ratio

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

111

0.90

0.06

1.3

1.5

2.00

1.08

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

111

0.90

0.06

1.3

1.5

1.39

1.30

ratio

—

(3007164) IgA [Mass/volume] in Serum or Plasma

496

1.04

0.05

1.6

1.4

2.06

2.19

g/l

0.21

324

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.09

0.03

1.3

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

108

0.92

0.03

1.3

1.5

—

(3022145) Colonoscopy Study observation

182

1.05

0.02

1.6

1.3

—

(3002256) Pathology report gross observation

218

0.96

0.02

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

162

1612

1.02

0.01

3.9

3.7

1.35

1.26

mmol/l

0.65

155

1523

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

463

1.02

0.01

2.4

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

314

1.02

0.00

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

154

0.97

0.00

3.9

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

277

1.01

0.00

4.4

4.1

22.40

22.18

—

106

(36660697) Celiac disease serology panel - Serum

195

1.03

0.00

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

0.00

0.0

1.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

4.6

—

644.78

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

0.0

22.0

—

101.67

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

13.8

—

163.60

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

160

1.00

-0.00

4.0

6.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

15.33

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.3

—

10.65

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

11.1

—

15.73

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.3

—

4.60

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.99

-0.00

1.3

1.5

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

5.6

—

8.44

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.86

-0.00

1.2

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.00

-0.00

0.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

6.43

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

1.62

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

2.6

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

54.50

—

(3012441) Differential panel - Pleural fluid

0.00

-0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

15.00

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.00

-0.00

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.36

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1513.63

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.00

-0.00

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

-0.00

0.0

1.0

—

0.66

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

0.60

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE – Superficial injury of ankle and foot, unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Superficial injury of ankle and foot, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Superficial injury of ankle and foot, unspecified (ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints